The 12 closest competitors and alternatives to EDAP TMS SA among medical devices companies — ranked by similarity to what EDAP TMS SA actually does, not by market-cap band.
Subscribe to see EDAP TMS SA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycle—from development and marketing to manufacturing and servicing—of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.
EDAP TMS SA is a medical devices company headquartered in Vaulx-en-Velin, France. It is publicly listed (FOCL) with a market capitalisation of $201.6M. Xcout tracks 18 named people at EDAP TMS SA, including Ryan Rhodes (CEO & Director).
12 more named people on record for EDAP TMS SA, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to EDAP TMS SA by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Dornier MedTech is a medical-device company specializing in urology technologies, including extracorporeal shock wave lithotripsy systems, surgical lasers, and related treatment platforms. It serves urologists, hospitals, and other healthcare providers treating urinary stones and urologic conditions.
Medical Device
Focal Medical develops and manufactures the Focal One HIFU Robotic System, a non-invasive medical device that utilizes high-intensity focused ultrasound technology to precisely target and ablate prostate tissue. The company serves urologists and healthcare facilities by providing equipment for prostate cancer management that preserves healthy surrounding tissue and minimizes side effects for patients.
Similar medical devices company
Advanced MedTech Holdings operates as a fully integrated urology company that provides medical technologies for stone management and prostate health, alongside contract development and manufacturing organization (CDMO) services. Headquartered in Singapore and owned by Temasek Holdings, the company serves healthcare providers and patients globally through its portfolio of brands.
Medical Device
Focal Therapeutics provides the Focal One robotic system, which utilizes high-intensity focused ultrasound (HIFU) technology to non-invasively target and ablate prostate tissue for prostate cancer patients. The system is designed for urologists to precisely treat targeted lesions while sparing healthy surrounding tissue and minimizing side effects.
Therapeutic Devices
UroMems is a global medical device and biotechnology company headquartered in Eybens, France, developing innovative mechatronic implants like the UroActive system to treat urinary incontinence.
Similar medical devices company
Theraclion develops non-invasive, robotic medical devices that utilize high-intensity focused ultrasound (HIFU) for extracorporeal surgery. Its primary products include the SONOVEIN system for treating varicose veins and the ECHOPULSE system for treating thyroid nodules and breast fibroadenomas.
Similar medical devices company
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions. Delcath Systems, Inc. was established in 1988, with its corporate headquarters situated in New York, New York.
Similar medical devices company
MedicaMetrix develops medical devices for prostate health, specifically offering the ProstaMetrix platform to measure prostate volume and calculate Prostate Specific Antigen Density (PSAD) during routine clinical examinations. The company serves urologists and healthcare professionals by providing tools for the early detection and ongoing monitoring of prostate conditions such as prostate cancer and BPH.
Similar medical devices company
Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.
Similar medical devices company
Established in 1996 and based in Shenzhen, China, WIKKON is a medical device manufacturer specializing in urology and shock wave therapy equipment. The company engages in the research, engineering, and supply of high-tech medical devices and has been acquired by Advanced MedTech.
Similar medical devices company
Neurinnov is a medical technology company based in Montpellier, France, specializing in innovation within neurostimulation. The firm has developed a versatile technology platform designed to restore human functions in individuals suffering from functional deficiencies across multiple pathologies. Through its specialized medical research, the company creates clinical value and therapeutic solutions.
Similar medical devices company
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for EDAP TMS SAand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →